Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

NCT00165412 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT00165412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00165412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
Lead sponsor
Dana-Farber Cancer Institute
Phase
Observational
Overall status
Completed
Start date
July 31, 2005
Completion date
May 31, 2010
Enrollment
148 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, hodgkin's disease